Meta Intel and AMD lead AI news

Meta's new personal AI agent Muse is driving a major rally in technology stocks just days after its September 8 launch. The app hit the top of the US free app store charts within six days, pulling in over 900,000 downloads and earning a 4.9 rating from roughly 18,000 reviews. Meta's stock jumped 11.4 percent, adding about 190 billion dollars in market value. CPU makers Arm, Intel, and AMD also surged, with Arm up 17.1 percent, Intel up 12.1 percent, and AMD climbing nearly 10 percent. Investors see agentic AI as a bigger driver of CPU demand than traditional chatbots.

Amazon briefly blocked Muse from its marketplace, while Bill Ackman of Pershing Square doubled down on Meta, selling all his Alphabet shares and increasing his Meta stake by about 20 percent. JPMorgan analyst Doug Anmuth upgraded Meta with an $820 price target on September 10. Meta's stock rose over 19 percent in the same period Alphabet slipped into negative territory.

Palo Alto Networks is launching an AI cybersecurity service on Tuesday that draws on models from Anthropic and OpenAI. The tool is designed to help businesses detect security vulnerabilities and respond to AI-driven threats. Wedbush Securities expert Steven Wahrhaftig highlighted both Palo Alto Networks and CrowdStrike as well-positioned in the AI era, following recent breaches including the OpenAI-Hugging Face hack.

Joe Lonsdale told CNBC that AI labs should face liability for cyber and intellectual property damage rather than enjoying platform protections. He predicted AI will boost productivity to 3 to 5 percent in the 2030s and called robotics a GPT-3 moment. Lonsdale warned that routine offshored jobs in places like the Philippines and India face the biggest near-term risk from AI competition.

Software and cloud companies are cutting AI product prices and bundling features to compete with OpenAI and Anthropic. Buyers say vendors that do not heavily discount AI capabilities risk losing business. Some firms are turning to self-hosting to control costs as traditional software companies figure out how to keep up with rapidly improving AI providers.

Lucid deployed an AI sales agent called Lucid Concierge that sends personalized emails promoting California's MyFirstEV program, which offers a $3,500 discount on new vehicles. The Gravity SUV has up to 450 miles of EPA-estimated range, and the Air sedan starts around $64,900. The tool operates through Lucid's Salesforce account as the company works to cut costs before September 30.

Tokocrypto is building futures trading, AI Trading insights, and expanded tokenized stocks. The platform currently offers over 40 tokenized stocks and aims to reach 100 by the end of 2026. Tokenized stocks give users fractional ownership, dividend rights, and 24-hour trading access. Trump also announced an AI Force similar to Space Force and said he will appoint an AI czar, though he provided few details. Senate Minority Leader Chuck Schumer called for congressional action on AI regulation.

AI is becoming a core part of drug development in biopharma. Pfizer CEO Albert Bourla called AI a structural transformation for research and development. AstraZeneca's Pam Cheng said AI helps shorten timelines and automate manufacturing. Startups like Insilico Medicine are launching with AI at their core, while Alphabet's Isomorphic Labs and Xaira are also entering the space, attracting heavy venture capital investment.

Key Takeaways

  • Meta's Muse AI agent reached the top of US free app store charts within six days, drawing over 900,000 downloads and a 4.9 rating from about 18,000 reviews.
  • Meta shares rose 11.4 percent after Muse's launch, adding roughly 190 billion dollars in market value, while CPU stocks surged with Arm up 17.1 percent, Intel up 12.1 percent, and AMD up nearly 10 percent.
  • Bill Ackman sold all Alphabet shares and increased his Meta stake by about 20 percent, while JPMorgan upgraded Meta with an $820 price target.
  • Palo Alto Networks is launching an AI cybersecurity service using models from Anthropic and OpenAI to help businesses find and fix security vulnerabilities.
  • Joe Lonsdale says AI labs should face liability for cyber and IP damage, predicts 3 to 5 percent productivity growth in the 2030s, and warns offshored routine jobs face the biggest near-term AI risk.
  • Software and cloud companies are lowering AI product prices and bundling features to compete with OpenAI and Anthropic, with some turning to self-hosting to control costs.
  • Lucid deployed an AI sales agent called Lucid Concierge that sends personalized emails promoting California's MyFirstEV program, which offers a $3,500 vehicle discount.
  • Tokocrypto is adding futures trading, AI Trading insights, and tokenized stocks, aiming to reach 100 tokenized stocks by the end of 2026.
  • Trump announced an AI Force and said he will appoint an AI czar, but provided few details, drawing criticism from Senate Minority Leader Chuck Schumer and the Electronic Frontier Foundation.
  • AI is becoming central to drug development, with Pfizer, AstraZeneca, Insilico Medicine, Alphabet's Isomorphic Labs, and Xaira all investing heavily in AI-driven research and development.

Meta's Muse AI app sparks big rally in CPU stock prices

Meta launched a new personal AI agent called Muse on September 8. The app became the top free app in the US within six days with over 900,000 downloads. Investors reacted by pushing Meta shares up 11.4 percent. CPU makers Arm, Intel, and AMD also saw big gains because AI agents use more central processing power than traditional chatbots. Amazon briefly blocked Muse from shopping on its marketplace.

Meta's Muse AI agent fuels rally in CPU and tech stocks

Meta's new AI assistant Muse reached the top of US app store rankings within days of its September 8 launch. The app earned a 4.9 out of 5 rating from roughly 18,000 user reviews. Meta shares jumped 11.4 percent on Monday, adding about 190 billion dollars in market value. CPU companies Arm, Intel, and AMD surged 17.1 percent, 12.1 percent, and nearly 10 percent respectively. Investors believe agentic AI will require far more CPU computing than current chatbot models.

Meta's Muse AI agent drives surge in CPU chip stocks

Meta's Muse personal AI agent became the most downloaded free iPhone app in the US for three straight days. Analysts say Muse could attract hundreds of millions of users thanks to Meta's 3.6 billion daily active users. AI agents rely more on CPUs for inference tasks like planning and orchestration. Arm, Intel, and AMD all rose sharply on Monday. ARM sees server CPU market growth of 35 percent annually reaching 120 billion dollars by 2030, while AMD predicts 50 percent annual growth to 220 billion dollars by decade end.

Palo Alto Networks launches AI cybersecurity service

Palo Alto Networks is launching a new service that uses AI models from Anthropic and OpenAI. The service will help businesses find security vulnerabilities in their corporate systems. It is set to launch on Tuesday. Hackers are increasingly using AI to discover and exploit weaknesses in computer networks. The new service aims to detect and respond to these AI-driven threats more quickly.

Cybersecurity stocks positioned for the AI era

Wedbush Securities expert Steven Wahrhaftig discussed cybersecurity stocks that may benefit from the AI era. CrowdStrike and Palo Alto Networks were highlighted as well-positioned companies. These firms offer advanced AI-powered security solutions. Their tools help organizations defend against increasingly sophisticated cyber threats. The discussion followed recent breaches including the OpenAI-Hugging Face hack.

Joe Lonsdale urges AI labs to take responsibility for cyber and IP damage

Joe Lonsdale told CNBC that AI labs should face liability for cyber and intellectual property damage rather than being protected like platforms. He said AI systems that hack, leak, or copy data should leave the builder responsible. Lonsdale also predicted that AI will boost productivity to 3 to 5 percent in the 2030s and called robotics a GPT-3 moment. He warned that offshored routine jobs in places like the Philippines and India face the biggest near-term risk from AI competition.

Tokocrypto prepares tokenized stocks, futures, and AI trading tools

Tokocrypto is developing three new trading features including futures trading, AI Trading insights, and expanded tokenized stocks. The platform currently offers over 40 tokenized stocks and aims to reach 100 by the end of 2026. Tokenized stocks give users fractional ownership, dividend rights, and 24-hour trading access. Futures trading will allow two-way strategies and leverage. The AI Trading tool is meant to help users monitor market opportunities and make decisions more easily.

Lucid deploys AI sales agent Lucid Concierge before quarter-end

Lucid has launched an AI sales agent called Lucid Concierge that sends personalized emails to potential buyers. The emails promote California's MyFirstEV program, which offers a $3,500 discount on new Lucid vehicles. The Gravity SUV has up to 450 miles of EPA-estimated range, and the Air sedan starts around $64,900. The agent operates through Lucid's Salesforce account and sends individual messages rather than bulk marketing. Lucid is using the tool as it works to cut costs and reduce inventory before September 30.

Trump announces AI Force with few details

President Donald Trump announced the creation of an AI Force similar to Space Force and said he will appoint an AI czar. He did not explain what the position or the force will do. Senate Minority Leader Chuck Schumer criticized the move and called for congressional action on AI regulation. Some Republicans supported the announcement, while the Electronic Frontier Foundation expressed concern that the effort may focus too much on abstract safety instead of real issues like cybersecurity and AI-powered surveillance.

Tech firms cut AI product prices to compete with OpenAI and Anthropic

Software and cloud companies are lowering AI product prices and bundling AI features to compete with OpenAI and Anthropic. Many firms are unhappy with providers that charge extra for AI based on usage or completed tasks. A report noted that traditional software companies are still figuring out how to compete as OpenAI and Anthropic keep improving their technology. One buyer said vendors that do not heavily discount AI capabilities are unlikely to keep his business. Companies are also turning to self-hosting to control costs.

Bill Ackman sells Alphabet and doubles down on Meta

Bill Ackman of Pershing Square sold all his Alphabet shares after just one quarter. He used the money to increase his Meta Platforms stake by about 20% in the second quarter of 2026. Meta's new AI agent called Muse launched on September 8, 2026 and saw rapid early adoption. Meta's stock rose over 19% while Alphabet slipped into negative territory in the same period. JPMorgan analyst Doug Anmuth upgraded Meta with an $820 price target on September 10, 2026.

AI becomes essential tool in drug development

Artificial intelligence has become a core part of drug development in biopharma. Pfizer CEO Albert Bourla called AI a structural transformation for speeding up research and development. AstraZeneca's Pam Cheng said AI helps shorten development timelines and automate manufacturing. New biotech startups like Insilico Medicine are launching with AI at their core, creating a sub-genre called TechBio. Companies such as Alphabet's Isomorphic Labs and Xaira are also entering the space, attracting heavy venture capital investment.

Sources

NOTE:

This news brief was generated using AI technology (including, but not limited to, Google Gemini API, Llama, Grok, and Mistral) from aggregated news articles, with minimal to no human editing/review. It is provided for informational purposes only and may contain inaccuracies or biases. This is not financial, investment, or professional advice. If you have any questions or concerns, please verify all information with the linked original articles in the Sources section below.

AI Agent AI Stocks CPU Demand AI Cybersecurity AI Liability AI Productivity AI Competition AI Sales AI Trading AI Drug Development

Comments

Loading...